Data di Pubblicazione:
2021
Abstract:
We analyzed CTCAE adverse events of sequential Carbon Ion radiotherapy (CIRT) and immune checkpoint inhibitors (ICIs) in advanced melanoma patients. The frequencies of early and late adverse events (AEs) were 100% and 82% of patients, respectively. The frequency of G3+ AEs was in line with the literature.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Adverse events; Carbon ion radiotherapy; Carbon ion radiotherapy and immunotherapy combination; Immune checkpoint inhibitors; Mucosal melanoma
Elenco autori:
Cavalieri, S.; Ronchi, S.; Barcellini, A.; Bonora, M.; Vischioni, B.; Vitolo, V.; Villa, R.; Del Vecchio, M.; Licitra, L.; Orlandi, E.
Link alla scheda completa:
Pubblicato in: